Belhaven Biopharma
Discover Belhaven Bio's needle-free Epipen alternative, fast-acting nasal medication for those with a fear of needles.
$10M Series A ·
Source: startupintros.com
Total raised: $21M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredAug 12, 2020 (6 years old)
About Belhaven Biopharma
Safe, allergy relief without injections
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $10M | — | startupintros.com | |
| Seed | $11M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
DN
Dave Neal FounderSL
Scott Lyman FounderDW
Derek Winstanly Independent Director
Investors
Companies like Belhaven Biopharma
WWizard Wellness$7M Seed · Sep 2026
DDelixSeries A · Nov 2026
SSoundHealthSeries A · Aug 2026
BBiolinq$100M Series B+ · Apr 2025
NNeurent Medical$67.5M · Feb 2026
HHelioWave Technologies
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/belhaven-biopharma (get a free API key).